IL4I1-IN-1

Overview

IL4I1-IN-1 (Compound Ex 232 pg 200) is a selective interleukin 4-induced protein 1 ( IL4I1 ) inhibitor with an EC 50 of 2 nM. IL4I1-IN-1 inhibits IL4I1-mediated oxidative deamination of phenylalanine, reducing the production of phenylpyruvate, H 2 O 2 and NH 3 . IL4I1-IN-1 is promising for research of cancers with high IL4I1 expression, such as endometrial carcinoma, ovarian cancer , and triple-negative breast cancer .

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Ovarian Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-174262
• CAS No.: 3082703-49-6
• Molecular Formula: C18H16ClN3O3
• Molecular Weight: 357.79
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.99 mM); Clear solution
• Availability: In-stock

Source

Original product source